Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiotepa, Fludarabine, and Melphalan in Alternative Donor Transplants
NCT03342196Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Mar 2018
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in hematologic malignancy, sponsored by Case Comprehensive Cancer Center. Started Mar 2018; status: completed.
02
Drugs
thiotepa
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT03342196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03342196.